BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Eflornithine

An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.

298+ PubMed studies analyzed · 25 RCTs · Evidence Score: 48.2

Research Domains

Eflornithine has been studied across 15 research domains including 😴 Sleep, 🔬 Oncology, ✨ Skin & Hair, 💪 Strength & Power, ⚡ Energy & Fatigue. The primary research focus is 😴 Sleep with 16% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Eflornithine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

trolox
2 shared targets
Kynurenic
2 shared targets
Cytarabine
2 shared targets
Propranolol
2 shared targets
Spermine
2 shared targets
Levodopa
2 shared targets
Buspirone
2 shared targets
Vitamin
2 shared targets
Lovastatin
2 shared targets
Methotrexate
2 shared targets
Loading evidence profile...

This evidence profile for Eflornithine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.